Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Sep 26, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹39.03-2.16% 1 day change | 20.94% p.a. | App exclusive | ₹6,162 Cr |
AUM (Fund size) | ₹6,162 Cr |
Exit load | 1.0% Exit load of 1% if redeemed within 15 days.! |
Lock-in Period | Nil |
Age | 7 yrs 3 m since Jun 25, 2018 |
Benchmark | BSE Healthcare TRI |
Min. investment | This scheme is currently not buyable |
Expense ratio | 1.88% as on Aug 31, 2025 |
Plan type | Regular |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | -1.59% | -1.58% |
3 Months | -0.91% | -2.06% |
6 Months | 7.82% | 4.18% |
1 Year | 0.05% | -2.96% |
2 Years | 26.84% | 21.59% |
3 Years | 26.79% | 22.12% |
4 Years | 16.4% | 13.29% |
5 Years | 19.52% | 16.81% |
7 Years | 20.76% | 18.92% |
Large Cap 49.56%
Mid Cap 16.32%
Small Cap 30%
Other Cap 0%
Healthcare 90.20000000000002%
Services 3.14%
Chemicals 1.43%
Insurance 1.1%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Repo 3.62641363%
Net Current Assets 0.35552407%
Cash Margin 0.13640785%
Others 0.36%
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -1.59% | 7.82% | 0.05% | 26.79% | 19.52% | N.A. |
SBI Healthcare Opportunities Fund | -1.82% | 2.09% | 0.02% | 24.46% | 18.75% | 10.81% |
DSP Healthcare Fund | -1.82% | 2.44% | -6.15% | 22.13% | 16.86% | 14.31% |
Tata India Pharma & Healthcare Fund | -1.38% | 4.72% | -3.75% | 21.66% | 17.13% | 11.57% |
Mirae Asset Healthcare Fund | -0.99% | 3.4% | -3.37% | 19.92% | 16.8% | 14.21% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.51 | 0.94 | 1.27 | 1.79 |
SBI Healthcare Opportunities Fund | 13.91 | 0.84 | 1.29 | 1.93 |
DSP Healthcare Fund | 14.57 | 0.84 | 1.14 | 1.87 |
Tata India Pharma & Healthcare Fund | 15.94 | 0.97 | 1.0 | 1.54 |
Mirae Asset Healthcare Fund | 16.36 | 1.0 | 0.86 | 1.36 |
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,162 Cr | 7 yrs 3 m | 1.88% |
SBI Healthcare Opportunities Fund | N.A. | 3,963 Cr | 26 yrs 3 m | 1.93% |
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 10 m | 1.93% |
Tata India Pharma & Healthcare Fund | N.A. | 1,232 Cr | 9 yrs 9 m | 2.1% |
Mirae Asset Healthcare Fund | N.A. | 2,796 Cr | 7 yrs 3 m | 1.93% |
Alpha | 3.55 vs. 5.81 Underperformed at beating benchmark |
Sharpe | 1.27 vs. 3.71 Poor risk-adjusted returns |
Beta | 0.94 vs. 0.71 More sensitive to market's ups & downs |
Standard deviation | 15.51 vs. 9.06 More volatile performance |
Fund AUM | 6,162 Cr as on Aug 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
No. of schemes | 103 view all schemes |
Total AUM | 9,83,726 Cr as on Jun 30, 2025 |
Address | One BKC , A Wing , 13th Floor, Bandra Kurla Complex, Mumbai, 400051 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
ICICI Prudential Infrastructure Fund | N.A. | 7,645 Cr | -4.71% | 36.81% |
ICICI Prudential Dividend Yield Equity Fund | N.A. | 5,779 Cr | -3.09% | 28.9% |
ICICI Prudential Smallcap Fund | N.A. | 8,441 Cr | -6.16% | 27.37% |
ICICI Prudential Large & Mid Cap Fund | N.A. | 23,698 Cr | -1.48% | 27.27% |
ICICI Prudential Value Fund | N.A. | 53,750 Cr | -1.34% | 26.25% |
ICICI Prudential India Equity FOF | N.A. | 219 Cr | -3.05% | 25.78% |
The current Net Asset Value (NAV) of the ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund plan is approximately ₹39.03 as of Sep 26, 2025.
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund is a 7 yrs 3 m old fund and has delivered average annual returns of 20.94% since inception.
1-Year | 3-Year | 5-Year | Since Inception |
---|---|---|---|
0.05% | 26.79% | 19.52% | 20.94% |
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has an expense ratio of 1.88%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund currently has assets under management (AUM) or fund size valued at approximately 6,162 Cr as on Aug 31, 2025.
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.71% |
Dr. Reddy's Laboratories Ltd. | 9.47% |
Divi's Laboratories Ltd. | 9.23% |
Cipla Ltd. | 7.39% |
Aurobindo Pharma Ltd. | 6.53% |
Lupin Ltd. | 5.44% |
Alkem Laboratories Ltd. | 4.0% |
Mankind Pharma Ltd. | 3.5% |
Biocon Ltd. | 3.21% |
Gland Pharma Ltd. | 2.88% |
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 90.20000000000002% |
Services | 3.14% |
Chemicals | 1.43% |
Insurance | 1.1% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.